Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 150
» View wsbtradio.com items only
    May 17, 2013 |Story| Reuters
  1. Dow, S&P end at records, stocks mark fourth week of gains

    NEW YORK (Reuters) - Stocks continued their climb into uncharted territory on Friday, racking up the fourth week of gains in a row as encouraging economic data prompted investors to pick up shares of growth companies.
    Reuters
    NEW YORK (Reuters) - Stocks continued their climb into uncharted territory on Friday, racking up the fourth week of gains in a row as encouraging economic data prompted investors to pick up shares of growth companies. The Dow and the S&P 500 finished...

    Tags: Tyson Foods Incorporated, Warren Buffett, Fossil Incorporated, U.S. Department of Energy, Philadelphia (Philadelphia, Pennsylvania)

  2. May 16, 2013 |Story| Reuters
  3. Espionage, comedy veterans touted for upcoming U.S. TV season

    Reuters
    By Liana B. Baker NEW YORK, May 16 (Reuters) - The big four U.S. broadcast networks, in need of new TV hits to turn around slumping ratings, are betting espionage programs and old comedy stars will convince advertisers to spend about $9 billion during...

    Tags: Modern Family (tv program), Central Intelligence Agency, FBI, NBC (tv network), Media Industry

  4. May 16, 2013 |Story| Reuters
  5. Espionage, comedy veterans touted for upcoming TV season

    Reuters
    NEW YORK (Reuters) - The big four U.S. broadcast networks, in need of new TV hits to turn around slumping ratings, are betting espionage programs and old comedy stars will convince advertisers to spend about $9 billion during the so-called upfront selling...

    Tags: Modern Family (tv program), Central Intelligence Agency, FBI, NBC (tv network), Media Industry

  6. May 16, 2013 |Story| Reuters
  7. Chief executives and the itch to quit

    LONDON (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds".
    Reuters
    LONDON (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief executives at European blue chip companies -...

    Tags: Belgium, Blue Chip Stocks, ABB Ltd., Delhaize Group, Science and Technology

  8. May 15, 2013 |Story| Reuters
  9. Elan says Royalty wanted to take it private before Tysabri deal

    Reuters
    DUBLIN, May 15 (Reuters) - Royalty Pharma last year urged Elan to hold off on a multi-billion dollar drug deal until it had taken the Irish drugmaker private to boost the compensation the firms' executives would receive, Elan said on Wednesday. Royalty...

    Tags: Shareholders, Companies and Corporations, Theravance Incorporated, Biogen Idec Incorporated, Economy, Business and Finance

  10. May 15, 2013 |Story| Reuters
  11. Bristol melanoma drug combo marks new advance in immunotherapy

    Reuters
    (For more stories on new cancer data, see ) By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance...

    Tags: Skin Cancer, Renal cell carcinoma, Food and Drug Administration, Lung Cancer, Trials

  12. May 14, 2013 |Story| AP Broadcast
  13. India announces development of cheap vaccine against major cause of diarrhea deaths in kids

    Associated Press
    NEW DELHI (AP) — The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world. The Indian...

    Tags: Family, Health Organizations, Disease Prevention, Drugs and Medicines, Science and Technology

  14. May 13, 2013 |Story| Reuters
  15. Wall St termina plano tras recientes máximos

    Reuters
    Por Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...

    Tags: S&P 500, Financial Markets, Nasdaq Composite, Theravance Incorporated, Stock Market

  16. May 13, 2013 |Story| AP Broadcast
  17. Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales

    Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline. The deal announced Monday will give Elan 21 percent of the future...

    Tags: Food and Drug Administration, Health Organizations, Moody's Corporation, Theravance Incorporated, Elan Corporation Plc

  18. May 13, 2013 |Story| AP Broadcast
  19. Stocks drop even as retail sales unexpectedly rise; record-breaking rally takes pause

    NEW YORK (AP) — Stocks are mixed in midday trading, pausing a record-breaking stock rally even after the government reported that Americans increased spending last month. The Dow fell 22.86, or 0.2 percent, to 15,096 as of 11:50 Eastern Daylight...

    Tags: Standard & Poor's Financial Services LLC, Theravance Incorporated, Kentucky Fried Chicken, Elan Corporation Plc

  20. May 9, 2013 |Story| Reuters
  21. Merck, Glaxo reducen precio de vacuna contra cáncer cervical para países pobres

    Reuters
    Por Kate Kelland LONDRES, 9 mayo (Reuters) - Las farmacéuticas Merck y GlaxoSmithKline redujeron el precio de las vacunas contra el cáncer de cuello de útero en un acuerdo que les permitirá venderlas a los países más pobres por menos de 5 dó...

    Tags: HPV Vaccine, Merck & Company Incorporated, Viral Diseases and Infections

  22. May 8, 2013 |Story| Reuters
  23. REUTERS SUMMIT-Drugmakers split as demands for open data mount

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Growing demands for transparency of clinical trial data * Wider disclosure by EU regulator angers drugmakers * GlaxoSmithKline sets up online system for data...

    Tags: Food and Drug Administration, Politics, Science and Technology, Trials, Merck & Company Incorporated

 1  2 3 4 5 6 7 8 9 10 11-13Next >
Original site for GlaxoSmithKline PLC topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
GlaxoSmithKline PLC Photos
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Third grader Kira Lingle of Quakertown rolls up a strea...
(July 10, 2012)
Science in the Summer program
A bottle of Xenical, a weight-loss aid made by GlaxoSmi...
(May 9, 2012)
GlaxoSmithKline launches hostile tender offer for Human Genome Sciences